Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Epirubicin|DRUG: Capecitabine
Sponsor: Craig A. Bunnell, MD, MPH
Collaborators: Dana-Farber Cancer Institute|Massachusetts General Hospital|Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Pharmacia